Total Payments
$4,457
2024 Payments
$1,782
Companies
19
Transactions
152
Payment Breakdown by Category
Food & Beverage$4,457 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,457 | 152 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,485 | 47 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,119 | 24 | $0 (2024) |
| Lilly USA, LLC | $497.98 | 18 | $0 (2024) |
| Novo Nordisk Inc | $412.12 | 16 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $172.92 | 10 | $0 (2024) |
| PFIZER INC. | $135.60 | 7 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $130.82 | 4 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $93.55 | 5 | $0 (2024) |
| Merck Sharp & Dohme LLC | $54.74 | 3 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $53.73 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,782 | 70 | AstraZeneca Pharmaceuticals LP ($727.06) |
| 2023 | $1,341 | 43 | AstraZeneca Pharmaceuticals LP ($525.96) |
| 2022 | $860.76 | 28 | Boehringer Ingelheim Pharmaceuticals, Inc. ($321.80) |
| 2021 | $473.11 | 11 | Boehringer Ingelheim Pharmaceuticals, Inc. ($224.97) |
All Payment Transactions
152 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: Neuropsychiatry | ||||||
| 11/12/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/12/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: PSYCHIATRY | ||||||
| 11/12/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: Diabetes | ||||||
| 11/06/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: Neuropsychiatry | ||||||
| 10/23/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: PSYCHIATRY | ||||||
| 10/15/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.47 | General |
| Category: DIABETES | ||||||
| 10/09/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: Diabetes | ||||||
| 10/01/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: Neuropsychiatry | ||||||
| 09/25/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.54 | General |
| Category: PSYCHIATRY | ||||||
| 09/24/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $24.33 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/24/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $26.85 | General |
| Category: DIABETES | ||||||
| 09/20/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: Diabetes | ||||||
| 09/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $96.61 | General |
| Category: DIABETES | ||||||
| 09/18/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $17.02 | General |
| 09/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $103.32 | General |
| Category: Respiratory | ||||||
| 09/11/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $22.93 | General |
| Category: Respiratory | ||||||
| 09/11/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.43 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/04/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $27.73 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/26/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $22.24 | General |
| 08/14/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: VACCINE | ||||||
| 08/14/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: Diabetes | ||||||
| 08/13/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/31/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: Respiratory | ||||||
About Jacqueline Fox
Jacqueline Fox is a Nurse Practitioner healthcare provider based in Boston, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/15/2020. The National Provider Identifier (NPI) number assigned to this provider is 1447875430.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jacqueline Fox has received a total of $4,457 in payments from pharmaceutical and medical device companies, with $1,782 received in 2024. These payments were reported across 152 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($4,457).
Ad
Practice Information
- Specialty Nurse Practitioner
- Location Boston, MA
- Active Since 06/15/2020
- Last Updated 09/25/2025
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1447875430
Products in Payments
- JARDIANCE (Drug) $1,245
- FARXIGA (Drug) $713.82
- BREZTRI (Drug) $383.33
- AIRSUPRA (Drug) $314.50
- MOUNJARO (Drug) $225.02
- ELIQUIS (Drug) $135.60
- EMGALITY (Drug) $131.75
- REXULTI (Drug) $131.50
- Austedo XR (Drug) $130.82
- Saxenda (Drug) $125.00
- Kerendia (Drug) $93.55
- Rybelsus (Drug) $64.54
- INGREZZA (Drug) $53.73
- PreHevbrio (Drug) $51.64
- NEXLETOL (Drug) $46.03
- SOLIQUA 100/33 (Biological) $43.83
- JYNARQUE (Drug) $41.90
- Ozempic (Drug) $41.75
- Wegovy (Drug) $37.75
- GARDASIL 9 (Biological) $35.98
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Boston
Ms. Pamela Calarese, Rn Np, RN NP
Nurse Practitioner — Payments: $99,590
Nurse Practitioner $99,590
Teresa Fogaren, Agnp-C, AGNP-C
Nurse Practitioner — Payments: $86,708
Nurse Practitioner $86,708
Lauren Burke
Nurse Practitioner — Payments: $25,208
Nurse Practitioner $25,208
Ashley Hilmes, Np, NP
Nurse Practitioner — Payments: $15,134
Nurse Practitioner $15,134
Mrs. Kelly Goodwin, Aprn, APRN
Nurse Practitioner — Payments: $13,610
Nurse Practitioner $13,610
Rebecca Rathburn, Aprn, APRN
Nurse Practitioner — Payments: $13,521
Nurse Practitioner $13,521